Document Detail


Where is the "M" in maternal-fetal medicine?
MedLine Citation:
PMID:  21099610     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In contrast to the generally encouraging trend regarding global maternal mortality, there has been an apparent increase in the maternal mortality ratio in the United States. Although maternal death remains a relatively rare adverse event in this country, programs to reduce maternal mortality also will result in a reduction in maternal morbidity, which is a far more prevalent problem. Progress in the field of maternal-fetal medicine over the past several decades has been largely attributable to improvements in fetal and neonatal medicine. We need to develop an organized, national approach focused on reducing maternal mortality and morbidity. The goal will be to outline a specific plan for clinical, educational, and research initiatives to put the "M" back in maternal-fetal medicine.
Authors:
Mary E D'Alton
Publication Detail:
Type:  Editorial    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  116     ISSN:  1873-233X     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-24     Completed Date:  2011-01-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1401-4     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Fetal Diseases / therapy
Humans
Infant, Newborn
Maternal Mortality* / trends
Obstetrics / organization & administration*
Pregnancy
Pregnancy Complications / prevention & control,  therapy
United States / epidemiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Electronic fetal monitoring as a public health screening program: the arithmetic of failure.
Next Document:  Evaluating the safety and effectiveness of new drugs.